title: 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver.
abstract: Several studies have implicated endocannabinoids in various forms of shock. However, the role of endocannabinoids in hepatic ischemia-reperfusion injury remains unclear. The purpose of this study was to evaluate the changes of two endocannabinoidsin hepatic ischemia-reperfusion injury: anandamide (ANA) and 2-arachidonoylglycerol (2-AG). Male Sprague-Dawley rats were divided into 2 groups: the short (15 min) ischemic group and the long (60 min)ischemic group in the segmental (70%) hepatic tissue. Blood levels of aspartate transaminase (AST), alanine transaminase (ALT), lactate dehydrogenase (LDH), ANA, and 2-AG were examined. Serum lev-els of AST, ALT, and LDH were significantly higher in the long-ischemia group than in the short-ischemia group. Plasma levels of 2-AG showed similar augmentation prior to and after reperfusion in both the short- and long-ischemia groups, although plasma 2-AG lev-els tended to be higher in the long-ischemia group than in the short-ischemia group. Plasma levels of ANA were augmented in the early phase of reperfusion in the short-ischemia group and did not differ significantly from the normal level with time after reperfusion in the long-ischemia group. These results suggest that the endocannabinoid 2-AG increases in hepatic ischemia-reperfusion injury of rats, rather than ANA.
authors.affiliation: Second Department of Surgery, Gunma University School of Medicine, Maebashi, Japan.
authors.forename: Makoto
authors.initials: M
authors.lastname: Kurabayashi
authors.forename: Izumi
authors.initials: I
authors.lastname: Takeyoshi
authors.forename: Daisuke
authors.initials: D
authors.lastname: Yoshinari
authors.forename: Koshi
authors.initials: K
authors.lastname: Matsumoto
authors.forename: Ikuro
authors.initials: I
authors.lastname: Maruyama
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Morishita
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001095:Arachidonic Acids / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood; D063385:Cannabinoid Receptor Modulators / Q000097:blood*; D063388:Endocannabinoids; D005989:Glycerides / Q000097:blood*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008107:Liver Diseases / Q000097:blood* / Q000473:pathology; D008297:Male; D053284:Polyunsaturated Alkamides; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000097:blood* / Q000473:pathology; D013997:Time Factors
chemical_list: D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D005989:Glycerides; D053284:Polyunsaturated Alkamides; C094503:glyceryl 2-arachidonate; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C078814:anandamide